The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism / Q000502:physiology; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008032:Limbic System / Q000378:metabolism; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D010672:Phenytoin / Q000494:pharmacology*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D012110:Reserpine / Q000037:antagonists & inhibitors; D012399:Rotation; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000502:physiology
D002395:Catecholamines; D011954:Receptors, Dopamine; D010672:Phenytoin; D012110:Reserpine; D001058:Apomorphine; D003913:Dextroamphetamine; D004298:Dopamine